01/08/2025 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2025 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 7:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/13/2024 4:02 PM | Moleculin Biotech (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/11/2024 7:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2024 11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
12/03/2024 4:20 PM | Moleculin Biotech (Filer)
| Form POS AM | |
11/18/2024 7:20 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2024 7:20 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 7:35 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 7:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
11/12/2024 6:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2024 4:09 PM | Moleculin Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024 7:00 PM | KLEMP WALTER V (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 7:00 PM | Foster Jonathan P. (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 7:03 PM | Moleculin Biotech (Issuer) PICKER DONALD H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 7:03 PM | CANNON MICHAEL D (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 7:03 PM | George Robert E. (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 7:04 PM | Climaco John M (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 7:05 PM | Cermak Elizabeth (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2024 7:06 PM | Moleculin Biotech (Issuer) Yan Joy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 4:27 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 3:43 PM | Moleculin Biotech (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/25/2024 3:16 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 7:40 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 7:00 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 7:31 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/16/2024 7:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/09/2024 7:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 4:15 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
08/19/2024 3:10 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 9:06 AM | Moleculin Biotech (Filer)
| Form 424B3 | |
08/16/2024 3:54 PM | Moleculin Biotech (Filer)
| Form 424B4 | |
08/15/2024 11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
08/15/2024 10:21 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
08/14/2024 8:57 PM | Moleculin Biotech (Filer)
| Form S-1/A | |
08/14/2024 7:05 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/05/2024 8:05 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/01/2024 7:35 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
A simple pattern that works in any market (Ad) Right when most traders were getting bearish, The All-Weather Pattern signaled something different.
Following this setup could've turned every $1,000 into $1,770 in just 48 hours.
But here's what really gets me excited...
You don't need to be glued to your screen all day, no complex formulas, no guessing.
Just wait for a stock to close below The All-Weather Pattern, then check if it opens higher the next morning.
That's it.
While of course I cannot promise future returns or against losses…
I've put together a complete breakdown of how this works, including the new stock that’s tending towards The All-Weather Pattern this week. If you’re interested, the complete details are all here. |
07/30/2024 6:00 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
07/22/2024 4:31 PM | Moleculin Biotech (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/10/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/05/2024 4:01 PM | KLEMP WALTER V (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
06/25/2024 5:00 PM | KLEMP WALTER V (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:01 PM | Foster Jonathan P. (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 5:02 PM | Moleculin Biotech (Issuer) PICKER DONALD H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:00 PM | KLEMP WALTER V (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:01 PM | Foster Jonathan P. (Reporting) Moleculin Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:01 PM | Moleculin Biotech (Issuer) PICKER DONALD H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 7:00 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 4:05 PM | Moleculin Biotech (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/16/2024 7:32 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 7:38 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:16 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/13/2024 6:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 7:31 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:55 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/02/2024 8:00 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 4:15 PM | Moleculin Biotech (Filer)
| Form 10-K/A | |
04/25/2024 7:23 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/08/2024 4:14 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2024 8:05 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 2:03 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 6:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 6:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 3:31 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 7:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 8:30 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 4:19 PM | Moleculin Biotech (Filer)
| Form 424B3 | |
02/15/2024 8:15 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 3:36 PM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 2:43 PM | ARMISTICE CAPITAL, LLC (Filed by) Moleculin Biotech (Subject)
| Form SC 13G | |
02/12/2024 11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
02/02/2024 4:05 PM | Moleculin Biotech (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
01/24/2024 7:50 AM | Moleculin Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |